A Phase I/II Trial of Palbociclib, Pembrolizumab, and Endocrine Therapy for Patients with HR+/HER2- Locally Advanced or Metastatic Breast Cancer (MBC): Clinical Outcomes and Stool Microbial Profiling.
Journal of Clinical Oncology(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要